Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19

Clinical trial NCT04751682 · COMPLETED

Trial details

NCT number: NCT04751682
Sponsor: Bharat Biotech International Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

SARS-CoV Infection

Start date: 2021-03-01
Primary completion: 2021-06-25
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.